THOMAS GREER: Open Payments
NPI 1275142325 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,916 in 99 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $852 · 2025 $1,916
Food & beverage: $1,848Education: $68
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $463 |
| ABBVIE INC. | 22 | $317 |
| Astellas Pharma US Inc | 11 | $246 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $176 |
| Ardelyx, Inc. | 4 | $104 |
| Indivior Inc. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 5 | $79 |
| Lilly USA, LLC | 4 | $72 |
| PFIZER INC. | 4 | $72 |
Products named: Auvelity, Veozah, CAPLYTA, VRAYLAR, IBSRELA, QULIPTA, SUBLOCADE, REXULTI.
Industry payments across LA — which companies pay providers there.
